Mangoceuticals Free Cash Flow (FCF) History (MGRX)
Mangoceuticals reported −$7.0M in free cash flow for fiscal 2023, a decrease of $5.6M from the previous fiscal year, with a free cash flow margin of −957.07%.
View full Mangoceuticals company overviewMangoceuticals free cash flow by year
2022
2023
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$7.0M | −$5.6M | — | −957.07% |
| 2022 | 2022-12-31 | −$1.4M | — | — | −15545.59% |
Mangoceuticals quarterly free cash flow
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | −$1.7M | — | — | −694.73% |
| Q3 2023 | 2023-09-30 | −$1.7M | — | — | −697.81% |
| Q2 2023 | 2023-06-30 | −$1.8M | — | — | −1260.71% |
| Q1 2023 | 2023-03-31 | −$1.8M | — | — | −1798.83% |
Mangoceuticals free cash flow growth trends
Mangoceuticals's latest reported quarter, Q4 2023, generated −$1.7M in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Mangoceuticals source filings ↗